1Barry BW.Lipid-protein-partitioning theory of skin penetration enhancement[J].] Controlled Release,1991,15: 237-240.
2Panigrahi L, Pattnaik S, Ghosal SK.Design and characterization of mucoadhesive buccal patches of salbutamol sulphate[J]. Acta Pol Pharm, 2004, 61 (5): 351-360.
3Charoo NA, Anwer A, Kohli K, et al. Transdermal delivery of flurbiprofen: permeation enhancement,design, pharmacokinetic, and pharmacodynamic studies in albino rats[J].Pharm Dev Technol, 2005,10 (3): 343-351.
4Zhao H, Lee CH, Chung SJ, et al.In vitro and in vivo evaluation of a novel nonscrotal matrix-type transdermal delivery system of testosterone[J].Drug Dev Ind Pharm, 2005, 31 (3): 257-261.
5Li GL, de Vries J J, van Steeg T J, et at. Transaermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment[J]. J Control Release, 2005, 101 (1-3); 199-208.
6Denet AR, Vanbever R, Preat V.Skin electroporation for transdermal and topical delivery[J]. Adv Drug Deliv Rev, 2004, 56 (5): 659-674.
8Radbruch L, Eisner F.Ciinical experience with transdermal fentanyl for the treatment of cancer pain in Germany[J].Keio J Med, 2004, 53 (1): 23-29.
9Mazieres B.Topical ketoprofen patch[J]. Drugs R D,2005, 6 (6): 337-344.
10Argoff CE, Galer BS, Jensen MP, et al. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale[J].Curr Med Res Opin, 2004, 20 (2): 21-28.
